Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Watson

Showing results (841-850 of 1,171) with videos related to

Pageof 118
Sort By:
Archives of Internal Medicine|September 13, 1993
DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family studyH T Lynch, P Watson, T A Conway, et al.
JAMA|May 14, 1997
Information needs and decisional preferences in women with breast cancerL F Degner, L J Kristjanson, D Bowman, et al.
Gut|March 25, 2006
Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumoursG B Turner, B T Johnston, D R McCance, et al.
The Journal of Biological Chemistry|January 24, 2013
Fucoidan is a novel platelet agonist for the C-type lectin-like receptor 2 (CLEC-2)Bhanu Kanth Manne, Todd M Getz, Craig E Hughes, et al.
Plos One|November 26, 2008
Differential roles of the PKC novel isoforms, PKCdelta and PKCepsilon, in mouse and human plateletsCatherine J Pears, Kelly Thornber, Jocelyn M Auger, et al.
Blood|November 24, 2001
C-terminal peptide of thrombospondin-1 induces platelet aggregation through the Fc receptor gamma-chain-associated signaling pathway and by agglutinationD Tulasne, B A Judd, M Johansen, et al.
Diseases of the Colon and Rectum|May 1, 1988
Differential diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome I and Lynch syndrome II)H T Lynch, P Watson, M Kriegler, et al.
Brain Research|December 28, 2011
The transport of nifurtimox, an anti-trypanosomal drug, in an in vitro model of the human blood-brain barrier: evidence for involvement of breast cancer resistance proteinChristopher P Watson, Murat Dogruel, Larisa Mihoreanu, et al.
The Journal of Biological Chemistry|November 1, 1996
p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2R M Kramer, E F Roberts, S L Um, et al.
Blood|August 25, 2017
CLEC-2 contributes to hemostasis independently of classical hemITAM signaling in miceElizabeth J Haining, Deya Cherpokova, Karen Wolf, et al.
Pageof 118

Showing results (841-850 of 1,171) with videos related to

Sort By:
Pageof 118
Archives of Internal Medicine|September 13, 1993
DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family studyH T Lynch, P Watson, T A Conway, et al.
JAMA|May 14, 1997
Information needs and decisional preferences in women with breast cancerL F Degner, L J Kristjanson, D Bowman, et al.
Gut|March 25, 2006
Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumoursG B Turner, B T Johnston, D R McCance, et al.
The Journal of Biological Chemistry|January 24, 2013
Fucoidan is a novel platelet agonist for the C-type lectin-like receptor 2 (CLEC-2)Bhanu Kanth Manne, Todd M Getz, Craig E Hughes, et al.
Plos One|November 26, 2008
Differential roles of the PKC novel isoforms, PKCdelta and PKCepsilon, in mouse and human plateletsCatherine J Pears, Kelly Thornber, Jocelyn M Auger, et al.
Blood|November 24, 2001
C-terminal peptide of thrombospondin-1 induces platelet aggregation through the Fc receptor gamma-chain-associated signaling pathway and by agglutinationD Tulasne, B A Judd, M Johansen, et al.
Diseases of the Colon and Rectum|May 1, 1988
Differential diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome I and Lynch syndrome II)H T Lynch, P Watson, M Kriegler, et al.
Brain Research|December 28, 2011
The transport of nifurtimox, an anti-trypanosomal drug, in an in vitro model of the human blood-brain barrier: evidence for involvement of breast cancer resistance proteinChristopher P Watson, Murat Dogruel, Larisa Mihoreanu, et al.
The Journal of Biological Chemistry|November 1, 1996
p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2R M Kramer, E F Roberts, S L Um, et al.
Blood|August 25, 2017
CLEC-2 contributes to hemostasis independently of classical hemITAM signaling in miceElizabeth J Haining, Deya Cherpokova, Karen Wolf, et al.
Pageof 118